Combined Graphene Oxide with 2-Methoxyestradiol for Effective Anticancer Therapy in-vitro Model

Katarzyna Uzdrowska,1 Narcyz Knap,1 Lucyna Konieczna,2 Anna Kamm,1 Alicja Kuban-Jankowska,1 Joanna Gierałtowska,3 Mariusz Belka,2 Magdalena Baran,3 Adrian Chlanda,3 Krystian Michał Kowiorski,3 Aleksander Żołnierski,4 Jacek Gulczynski,5 Ludwika Lipi&nacut...

Full description

Saved in:
Bibliographic Details
Main Authors: Uzdrowska K, Knap N, Konieczna L, Kamm A, Kuban-Jankowska A, Gierałtowska J, Belka M, Baran M, Chlanda A, Kowiorski KM, Żołnierski A, Gulczynski J, Lipińska L, Bączek T, Izycka-Swieszewska E, Górska-Ponikowska M
Format: Article
Language:English
Published: Dove Medical Press 2025-01-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/combined-graphene-oxide-with-2-methoxyestradiol-for-effective-anticanc-peer-reviewed-fulltext-article-IJN
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832592047726395392
author Uzdrowska K
Knap N
Konieczna L
Kamm A
Kuban-Jankowska A
Gierałtowska J
Belka M
Baran M
Chlanda A
Kowiorski KM
Żołnierski A
Gulczynski J
Lipińska L
Bączek T
Izycka-Swieszewska E
Górska-Ponikowska M
author_facet Uzdrowska K
Knap N
Konieczna L
Kamm A
Kuban-Jankowska A
Gierałtowska J
Belka M
Baran M
Chlanda A
Kowiorski KM
Żołnierski A
Gulczynski J
Lipińska L
Bączek T
Izycka-Swieszewska E
Górska-Ponikowska M
author_sort Uzdrowska K
collection DOAJ
description Katarzyna Uzdrowska,1 Narcyz Knap,1 Lucyna Konieczna,2 Anna Kamm,1 Alicja Kuban-Jankowska,1 Joanna Gierałtowska,3 Mariusz Belka,2 Magdalena Baran,3 Adrian Chlanda,3 Krystian Michał Kowiorski,3 Aleksander Żołnierski,4 Jacek Gulczynski,5 Ludwika Lipińska,3 Tomasz Bączek,2 Ewa Izycka-Swieszewska,5 Magdalena Górska-Ponikowska1 1Department of Medical Chemistry, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland; 2Faculty of Pharmacy, Medical University of Gdansk, Gdansk, Poland; 3Łukasiewicz Research Network - Institute of Microelectronics and Photonics, Warsaw, Poland; 4The Institute of Economic Sciences of the Polish Academy of Sciences, Warsaw, Poland; 5Faculty of Health Sciences with the Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Gdansk, PolandCorrespondence: Magdalena Górska-Ponikowska, Email magdalena.gorska-ponikowska@gumed.edu.plIntroduction: This article describes the invention of graphene oxide (GO) or reduced graphene oxide (rGO) functionalised with 2-methoxy estradiol. The presence of polar hydroxyl groups enables the binding of 2-ME to GO/rGO through hydrogen bonds with epoxy and hydroxyl groups located on the surface and carbonyl and carboxyl groups located at the edges of graphene flake sheets.Methods: The patented method of producing the subject of the invention and the research results regarding its anticancer effectiveness via cytotoxicity in an in vivo model (against A375 melanoma and 143B osteosarcoma cells) are described.Results: It was shown that the inhibition of PTP1B phosphotyrosine phosphatase is one of the mechanisms of action of GO functionalised with 2-ME (GO-2-ME). This is a very important result, considering the fact that 2-ME itself has no inhibitory properties against this phosphatase.Discussion: Graphene oxide flakes embroidered with 2-methoxyestradiol molecules may be a promising solution, bringing a new and important effect in the form of improving the bioavailability of the therapeutic substance, ie 2-ME. An appropriate dosage of GO-2-ME/rGO-2-ME, in which GO/rGO is a carrier of 2-methoxyestradiol (2-ME), can ensure effective penetration of the active substance through biological boundaries/membranes and controlled modification of cell signalling, ultimately leading to the selective elimination of malignant cells.Keywords: new graphene-based anticancer drugs, graphene-based oncological therapy, new anticancer treatment, biomedical innovations, drugs delivery systems
format Article
id doaj-art-11c6778927c5415cb14f28eda0b642c3
institution Kabale University
issn 1178-2013
language English
publishDate 2025-01-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj-art-11c6778927c5415cb14f28eda0b642c32025-01-21T16:58:06ZengDove Medical PressInternational Journal of Nanomedicine1178-20132025-01-01Volume 2093395099455Combined Graphene Oxide with 2-Methoxyestradiol for Effective Anticancer Therapy in-vitro ModelUzdrowska KKnap NKonieczna LKamm AKuban-Jankowska AGierałtowska JBelka MBaran MChlanda AKowiorski KMŻołnierski AGulczynski JLipińska LBączek TIzycka-Swieszewska EGórska-Ponikowska MKatarzyna Uzdrowska,1 Narcyz Knap,1 Lucyna Konieczna,2 Anna Kamm,1 Alicja Kuban-Jankowska,1 Joanna Gierałtowska,3 Mariusz Belka,2 Magdalena Baran,3 Adrian Chlanda,3 Krystian Michał Kowiorski,3 Aleksander Żołnierski,4 Jacek Gulczynski,5 Ludwika Lipińska,3 Tomasz Bączek,2 Ewa Izycka-Swieszewska,5 Magdalena Górska-Ponikowska1 1Department of Medical Chemistry, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland; 2Faculty of Pharmacy, Medical University of Gdansk, Gdansk, Poland; 3Łukasiewicz Research Network - Institute of Microelectronics and Photonics, Warsaw, Poland; 4The Institute of Economic Sciences of the Polish Academy of Sciences, Warsaw, Poland; 5Faculty of Health Sciences with the Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Gdansk, PolandCorrespondence: Magdalena Górska-Ponikowska, Email magdalena.gorska-ponikowska@gumed.edu.plIntroduction: This article describes the invention of graphene oxide (GO) or reduced graphene oxide (rGO) functionalised with 2-methoxy estradiol. The presence of polar hydroxyl groups enables the binding of 2-ME to GO/rGO through hydrogen bonds with epoxy and hydroxyl groups located on the surface and carbonyl and carboxyl groups located at the edges of graphene flake sheets.Methods: The patented method of producing the subject of the invention and the research results regarding its anticancer effectiveness via cytotoxicity in an in vivo model (against A375 melanoma and 143B osteosarcoma cells) are described.Results: It was shown that the inhibition of PTP1B phosphotyrosine phosphatase is one of the mechanisms of action of GO functionalised with 2-ME (GO-2-ME). This is a very important result, considering the fact that 2-ME itself has no inhibitory properties against this phosphatase.Discussion: Graphene oxide flakes embroidered with 2-methoxyestradiol molecules may be a promising solution, bringing a new and important effect in the form of improving the bioavailability of the therapeutic substance, ie 2-ME. An appropriate dosage of GO-2-ME/rGO-2-ME, in which GO/rGO is a carrier of 2-methoxyestradiol (2-ME), can ensure effective penetration of the active substance through biological boundaries/membranes and controlled modification of cell signalling, ultimately leading to the selective elimination of malignant cells.Keywords: new graphene-based anticancer drugs, graphene-based oncological therapy, new anticancer treatment, biomedical innovations, drugs delivery systemshttps://www.dovepress.com/combined-graphene-oxide-with-2-methoxyestradiol-for-effective-anticanc-peer-reviewed-fulltext-article-IJNnew graphene-based anticancer drugsgraphene- based oncological therapynew anticancer treatmentbiomedical innovationsdrugs delivery systems
spellingShingle Uzdrowska K
Knap N
Konieczna L
Kamm A
Kuban-Jankowska A
Gierałtowska J
Belka M
Baran M
Chlanda A
Kowiorski KM
Żołnierski A
Gulczynski J
Lipińska L
Bączek T
Izycka-Swieszewska E
Górska-Ponikowska M
Combined Graphene Oxide with 2-Methoxyestradiol for Effective Anticancer Therapy in-vitro Model
International Journal of Nanomedicine
new graphene-based anticancer drugs
graphene- based oncological therapy
new anticancer treatment
biomedical innovations
drugs delivery systems
title Combined Graphene Oxide with 2-Methoxyestradiol for Effective Anticancer Therapy in-vitro Model
title_full Combined Graphene Oxide with 2-Methoxyestradiol for Effective Anticancer Therapy in-vitro Model
title_fullStr Combined Graphene Oxide with 2-Methoxyestradiol for Effective Anticancer Therapy in-vitro Model
title_full_unstemmed Combined Graphene Oxide with 2-Methoxyestradiol for Effective Anticancer Therapy in-vitro Model
title_short Combined Graphene Oxide with 2-Methoxyestradiol for Effective Anticancer Therapy in-vitro Model
title_sort combined graphene oxide with 2 methoxyestradiol for effective anticancer therapy in vitro model
topic new graphene-based anticancer drugs
graphene- based oncological therapy
new anticancer treatment
biomedical innovations
drugs delivery systems
url https://www.dovepress.com/combined-graphene-oxide-with-2-methoxyestradiol-for-effective-anticanc-peer-reviewed-fulltext-article-IJN
work_keys_str_mv AT uzdrowskak combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel
AT knapn combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel
AT koniecznal combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel
AT kamma combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel
AT kubanjankowskaa combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel
AT gierałtowskaj combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel
AT belkam combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel
AT baranm combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel
AT chlandaa combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel
AT kowiorskikm combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel
AT zołnierskia combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel
AT gulczynskij combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel
AT lipinskal combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel
AT baczekt combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel
AT izyckaswieszewskae combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel
AT gorskaponikowskam combinedgrapheneoxidewith2methoxyestradiolforeffectiveanticancertherapyinvitromodel